More Articles

Trastuzumab biosimilar Herzuma approved in Canada Biosimilars/News | Posted 20/09/2019

South Korean biotechnology company Celltrion announced on 10 September 2019 that Health Canada had approved its trastuzumab biosimilar Herzuma.

UnitedHealthcare to preferentially cover Amgen’s anticancer biosimilars Biosimilars/General | Posted 20/09/2019

The largest insurer in the US, UnitedHealthcare, has announced it will preferentially cover Amgen’s biosimilar cancer treatments from 1 October 2019.

China approves new formulation of etanercept copy biological Yisaipu Biosimilars/News | Posted 20/09/2019

China’s National Medical Products Administration (NMPA), formerly the China Food and Drug Administration (CFDA), has approved Yisaipu, an etanercept copy biological as a pre-filled syringe.

FDA’s global inspection strategy strengthened Generics/General | Posted 20/09/2019

The US Food and Drug Administration (FDA) has implemented a modernized approach to ensure the safety and quality of globally produced innovator and generic medicines. Through its Program Alignment,...

Generics in Chile: policy success but promotion required Generics/Research | Posted 20/09/2019

A first-time evaluation [1] of Chile’s generics substitution policy has shown that there has been a decrease in sales of branded originator medicines since policy implementation in 2014. However, t...

Sandoz makes deal with Polpharma for natalizumab biosimilar Pharma News | Posted 20/09/2019

Sandoz, the generics division of Novartis, and Poland-based Polpharma Biologics announced on 3 September 2019 that they had signed a worldwide agreement giving Sandoz commercialization rights to Po...

Screening protein surface biosimilarity of rituximab using aptamers Biosimilars/Research | Posted 20/09/2019

Among the many features needed to prove sufficient biosimilarity to a licensed drug produced in living organisms, is coherency of the three-dimensional structure. The integrity thereof is vital for...

China eases generic medicine import laws Policies & Legislation | Posted 20/09/2019

China has revised its drug administration laws to allow the import and sale of small quantities of generic drugs which are not approved in China.